Philanthropic investors play a crucial role in funding early-stage cancer research that may be too risky for traditional investors. Organizations like the American Cancer Society and the National Cancer Institute provide grants and funding to researchers, helping to bridge the gap between basic research and clinical application. This funding can lead to breakthroughs that eventually attract commercial investment.
